Cargando…
The significance of preclinical anti-BP180 autoantibodies
Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease. Although the pathomechanism of BP onset has yet to be elucidated in detail, BP autoantibodies targeting two hemidesmosomal components, BP180 and BP230, are known to play a pivotal role in BP pathogenesis. Thus, th...
Autores principales: | Mai, Yosuke, Izumi, Kentaro, Mai, Shoko, Ujiie, Hideyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393388/ https://www.ncbi.nlm.nih.gov/pubmed/36003369 http://dx.doi.org/10.3389/fimmu.2022.963401 |
Ejemplares similares
-
Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180
por: Mai, Yosuke, et al.
Publicado: (2019) -
Anti-BP180 Autoantibodies Are Present in Stroke and Recognize Human Cutaneous BP180 and BP180-NC16A
por: Wang, Yanan, et al.
Publicado: (2019) -
Native Autoantigen Complex Detects Pemphigoid Autoantibodies
por: Mai, Shoko, et al.
Publicado: (2023) -
Use of gliptins reduces levels of SDF-1/CXCL12 in bullous pemphigoid and type 2 diabetes, but does not increase autoantibodies against BP180 in diabetic patients
por: Nätynki, Antti, et al.
Publicado: (2022) -
BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid
por: Liu, Yale, et al.
Publicado: (2017)